查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424475

全球黴漿菌測試市場：按產品類型、按應用、按最終用戶、按地區

Global Mycoplasma Testing Market, By Product Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球黴漿菌檢測市場規模預計將從2024年的 9.978 億美元增至2031年的 19.076 億美元，預測期內年複合成長率為 9.7%。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 9.978 億美元
實際資料 2019年至2023年 預測期 2024-2031
預測期2023/2024~2030/2031年複合成長率： 9.70% 2030/2031年預測值 19.076 億美元
圖 1.2024年黴漿菌檢測全球市場佔有率（%）（依地區）
全球支原體檢測市場-IMG1

黴漿菌檢測在生物技術和製藥領域非常重要。市面上有不同類型的黴漿菌檢測產品。主要產品可分為兩類：套件和服務。

套件是一個自足式的工具，可讓研究人員自行測試黴漿菌污染。這些套件包含測試所需的所有試劑和說明。最常見的套件類型是基於聚合酵素鏈鎖反應（PCR）的套件、基於酵素結合免疫吸附檢測法（ELISA）的套件和基於微生物學的套件。 PCR套件靈敏且特異性，但需要專門的設備。 ELISA套件易於使用，因為它們不需要專門的設備，但其靈敏度不如 PCR。微生物套件可直接檢測黴漿菌生長情況，但結果需要時間。

除了套件之外，許多公司還提供黴漿菌檢測服務，研究人員將樣本送到專門的檢測機構。該服務的優點是研究人員無需投資設備或培訓。服務機構經驗豐富的技術人員可以進行各種類型的測試，包括 PCR、ELISA 和微生物檢測，並提供報告。然而，結果可能需要一些時間，因為必須運送樣品。套件可以加快測試速度，但需要適當的基礎設施。兩種產品在不同情況下各有優勢，取決於各個實驗室的要求和能力。

市場動態：

市場參與者對研發（R＆D）活動的​​開拓預計將在預測期內推動市場成長。此外，市場參與企業增加有機和無機策略將促進預測期內的市場成長。

本研究的主要特點

  • 本報告對全球黴漿菌檢測市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
  • 闡明了不同細分市場的潛在收益成長機會，並解釋了該市場有吸引力的投資提案矩陣。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球黴漿菌測試市場的主要企業。
  • 本報告的見解使行銷人員和公司負責人能夠就未來的經營團隊發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球黴漿菌測試市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球黴漿菌檢測市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 市場相關人員活性化研發活動
    • 研發費用增加
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • PEST分析
  • 波特的分析
  • 合併、收購和合作

第4章 全球黴漿菌檢測市場 -冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球黴漿菌檢測市場，依產品類型，2019-2031

  • 套件和試劑
  • 裝置

第6章 全球黴漿菌檢測市場，依應用分類，2019-2031

  • 細胞株測試
  • 病毒檢測
  • 成品檢驗
  • 其他（原料檢驗等）

第7章 全球黴漿菌檢測市場，依最終用戶分類，2019-2031

  • 製藥和生物技術公司
  • 合約研究組織
  • 學術研究所

第8章 2019-2031年全球黴漿菌檢測市場，依地區

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • 公司簡介
    • Charles River Laboratories International
    • Merck KGaA
    • Lonza Group Ltd
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Merck
    • InvivoGen
    • Creative Bioarray
    • Other Prominent Players

第10章

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6579

Global mycoplasma testing market size is expected to reach US$ 1,907.6 Mn by 2031, from US$ 997.8 Mn in 2024, exhibiting a compound annual growth rate (CAGR) of 9.7% during the forecast period.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 997.8 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024-2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 9.70% 2030/2031 Value Projection: US$ 1,907.6 Mn
Figure 1. Global Mycoplasma Testing Market Share (%), By Region, 2024
Global Mycoplasma Testing Market - IMG1

Mycoplasma testing is essential in the field of biotechnology and pharmaceuticals. There are different types of products available in the market for mycoplasma testing. The major products can be categorized into two types - kits and services.

Kits are self-contained tools that allow researchers to test for mycoplasma contamination on their own. These kits have all the necessary reagents and instructions to perform the test. The most common types of kits are polymerase chain reaction (PCR)-based kits, enzyme-linked immunosorbent assay (ELISA) based kits, and microbiological-based kits. PCR kits are highly sensitive and specific but require specialized equipment. ELISA kits are easier to use as they don't need specialized equipment but are less sensitive than PCR. Microbiological kits involve detecting mycoplasma growth directly but take longer time to give results.

Along with kits, various companies offer mycoplasma testing as services where researchers can send their samples to specialized testing facilities. The advantage of services is that researchers do not need to invest in equipment or training. Experienced technicians at the service facilities perform different types of tests like PCR, ELISA, and microbiological assays and provide reports. However, there can be delays in getting results as samples need to be shipped. Kits allow for faster testing but require proper infrastructure. Both products have their advantages in different situations depending on individual lab requirements and capacities.

Market Dynamics:

Growing research and development (R&D) activities by the market players is expected drive the market growth over the forecast period. Moreover, increasing organic and inorganic strategies by the market players will aid in the market growth over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global mycoplasma testing market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global mycoplasma testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Charles River Laboratories International, Merck KGaA, Lonza Group Ltd, Roche Diagnostics, Thermo Fisher Scientific, Merck, InvivoGen, Creative Bioarray, and Other Prominent Players
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global mycoplasma testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mycoplasma testing market

Detailed Segmentation:

  • Global Mycoplasma Testing Market, By Product Type
    • Kits & Reagents
    • Instruments
  • Global Mycoplasma Testing Market, By Application
    • Cell Line Testing
    • Virus Testing
    • End of Production Testing
    • Others (Raw Material Testing, etc.)
  • Global Mycoplasma Testing Market, By End User
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Academic Research Institutes
  • Global Mycoplasma Testing Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Mycoplasma Testing Market:
    • Charles River Laboratories International.
    • Merck KGaA
    • Lonza Group Ltd
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Merck
    • InvivoGen
    • Creative Bioarray
    • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rising research and development activities by the market players
    • Increasing R&D Expenditure
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Mycoplasma Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Mycoplasma Testing Market, By Product Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031(%)
    • Y-o-Y Growth Analysis, 2020- 2031
    • Segment Trends
  • Kits & Reagents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Mycoplasma Testing Market, By Application, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031(%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Cell Line Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Virus Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • End of Production Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Others (Raw Material Testing, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Mycoplasma Testing Market, By End User, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031(%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
  • Academic Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Mycoplasma Testing Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031(%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Company Profile
    • Charles River Laboratories International
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Merck KGaA
    • Lonza Group Ltd
    • Roche Diagnostics
    • Thermo Fisher Scientific
    • Merck
    • InvivoGen
    • Creative Bioarray
    • Other Prominent Players
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us